ArticleThe journal of headache and pain2025
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study.
Damiana Scuteri et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it